ABBV: AbbVie Inc Company Value to Net Income

AbbVie Inc - graphic logo of issuer ABBV

AbbVie Inc. (ABBV) is a reliable pharmaceutical holding with high-quality earnings and stable FCF, and on GURU.Markets, this linear chart of its market cap-to-earnings valuation reaches 50.80. The business's resilience is based on diversification into aesthetics and neurology, while the inertial flow from immunology is successfully supplemented by new developments, preventing the company's financial metrics from fading.

Abbvie (ABBV) - Price to Earnings Ratio from 07/04/2022 to 11/15/2026

Comprehensive metric breakdowns and analytics for AbbVie (ABBV)

- price and consensus price forecast:
Stock Price Abbvie|ABBV - Consensus Target
- market capitalization information:
Market Value AbbVie Inc|ABBV - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value of a Share AbbVie|ABBV - Company Book Value|Market-to-Book Ratio abbvie.com|ABBV - Aggregate Company Assets
- debt and solvency information:
Debt to Equity AbbVie Inc.|ABBV - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio AbbVie Inc.|ABBV - Company Aggregate Debts|Debts to Net Assets Abbvie|ABBV - Company Long-Term Debt|Company Short-Term Indebtedness AbbVie|Critical Liquidity abbvie.com
- earnings and valuation multiples indicators:
ABBV - Net Profit|Projected Future Earnings AbbVie Inc.|ABBV - P/E Multiple|Future Price to Earnings Abbvie|ABBV - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AbbVie Corp.|ABBV - Operating profit before deduction of amortization|Earnings per share for the last twelve months AbbVie|ABBV - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months abbvie.com|ABBV - Earnings growth in current year|Expected net earnings per share growth next year AbbVie Inc.
- sales volume and revenue indicators:
ABBV - Company Sales|Company Future Revenue AbbVie|ABBV - P/S Multiple|Market Cap to Expected Sales Ratio Abbvie|ABBV - Sales Growth YoY (Last Twelve Months)
Summary company analysis:AbbVie Inc.
Brand item of abbvie.com

The P/E ratio reflects the market value of a single unit of net profit, determining the extent to which an asset is overvalued or undervalued. The historical P/E values for AbbVie Inc. (ABBV) on the GURU.Markets platform allow for an assessment of the stock's resilience to market shocks. The ratio is calculated by dividing the current share price by the annual earnings per share. For AbbVie Inc. (ABBV), this indicator confirms the effective monetization of long-term patents and the stability of cash flows from chronic disease treatments.

Analysis of competing companies

LLY: Company Value to Net Income|P/E Multiple AZN|NVS (Novartis Pharma) - Company Value to Net Income|Price to Earnings Ratio Merck & Co. MRK|novonordisk.com (NVO) - Market Cap to Earnings|AMGN - Price to Earnings Ratio|PFE: Price to Earnings Ratio|SNY: P/E Multiple|Price to Earnings Multiple BMY|GSK (GlaxoSmithKline) - P/E Multiple|takeda.com (TAK) - Business Payback Period|P/E Multiple TEVA|Dr. Reddy's - Price to Earnings Multiple|Price to Earnings Ratio Viatris Inc. VTRS|ROIV: Price to Earnings Multiple|Zai Lab Corp - P/E Multiple|BHC: Price to Earnings Ratio|COSM: P/E Multiple